Clinical Trial Update: Age-Related Eye Disease Study 2 (AREDS2) [Phase 3]

View source ↗

Summary

AREDS2 is a Phase 3 trial that has completed. It evaluated antioxidant and mineral supplementation for age-related macular degeneration and cataract.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Cataract

Drugs mentioned

• AREDS2 supplement formulation
• Beta-carotene (beta-carotene)
• Lutein (lutein)
• Vitamin C (ascorbic acid)
• Vitamin E (tocopherol)
• ZINC (Zinc chloride)
• Zeaxanthin (Zeaxanthin)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Age-related Macular Degeneration, Cataract | Phase 3 | Status: COMPLETED | Results posted: 2013-12-24